Last month, Brigham and Women’s Hospital (BWH) announced the launch of the Ann Romney Center for Neurologic Diseases, a global collaboration to accelerate treatments and cures for five of the world’s most complex and devastating neurologic diseases. The center will focus on multiple sclerosis (MS), Alzheimer’s disease, ALS (Lou Gehrig's disease), Parkinson’s disease and brain tumors.
Led by BWH neurologists Howard L. Weiner, M.D. and Dennis J. Selkoe, M.D. – two of the world’s most renowned experts in neurologic disease – the center aims to produce breakthrough, life-changing research to benefit patients confronting these devastating neurologic diseases. Dr. Weiner, a global leader in MS clinical care and research, and Dr. Selkoe, an Alzheimer’s expert, brought their own laboratories together in 1985. Their proven track record of firsts in neurologic discoveries inspired the novel, collaborative strategy embraced by the Ann Romney Center for Neurologic Diseases.
Promising advances in neurologic diseases often occur when research in one disease state is applied to other disease states. The center aims to fuel new types of collaboration across disease states by fostering real-time, informal information sharing among researchers and doctors that could lead to unexpected discoveries and applications for scientific research.
Ann Romney, who is living with MS and is a patient of Dr. Weiner, will champion the center’s mission. As The Boston Globe reported, federal funding for early-stage discovery can be difficult to secure because of its uncertain outcomes, so Mrs. Romney has committed to help BWH raise $50 million in funding to support the center’s research.
By combining BWH’s unique assets with the world’s most advanced resources and minds, we aim to give hope and empowerment to those confronting these devastating neurologic diseases and change outcomes for future generations.
Tags: research and discovery